HK1132263A1 - Dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis - Google Patents

Dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis

Info

Publication number
HK1132263A1
HK1132263A1 HK09110419.3A HK09110419A HK1132263A1 HK 1132263 A1 HK1132263 A1 HK 1132263A1 HK 09110419 A HK09110419 A HK 09110419A HK 1132263 A1 HK1132263 A1 HK 1132263A1
Authority
HK
Hong Kong
Prior art keywords
virosis
manufactures
treatment
prevention against
pharmaceutical medicaments
Prior art date
Application number
HK09110419.3A
Other languages
English (en)
Inventor
Song Li
Xuejun Zhu
Guoming Zhao
Lili Wang
Wu Zhong
Zhibing Zheng
Junhai Xiao
Original Assignee
Beijing Molecule Science And Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Molecule Science And Technology Co Ltd filed Critical Beijing Molecule Science And Technology Co Ltd
Publication of HK1132263A1 publication Critical patent/HK1132263A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK09110419.3A 2007-01-16 2009-11-16 Dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis HK1132263A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA2007100006883A CN101225084A (zh) 2007-01-16 2007-01-16 二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
PCT/CN2008/000022 WO2008086729A1 (fr) 2007-01-16 2008-01-03 Nouveaux composés de dihydropyrimidine et leurs utilisations dans la préparation de médicaments pharmaceutiques destinés au traitement et à la prévention des viroses

Publications (1)

Publication Number Publication Date
HK1132263A1 true HK1132263A1 (en) 2010-02-19

Family

ID=39635660

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110419.3A HK1132263A1 (en) 2007-01-16 2009-11-16 Dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis

Country Status (5)

Country Link
US (1) US8106196B2 (xx)
EP (1) EP2135866B1 (xx)
CN (2) CN101225084A (xx)
HK (1) HK1132263A1 (xx)
WO (1) WO2008086729A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2159224B1 (en) * 2007-06-18 2012-08-01 Sunshine Lake Pharma Co., Ltd Bromo-phenyl substituted thiazolyl dihydropyrimidines
US20130267517A1 (en) 2012-03-31 2013-10-10 Hoffmann-La Roche Inc. Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
PL2888241T3 (pl) 2012-08-24 2017-12-29 Sunshine Lake Pharma Co., Ltd. 2,4,5,6-Podstawione pochodne 3,6-dihydropirymidyny jako inhibitory polimerazy wirusa zapalenia wątroby typu B (HBV) do leczenia np. przewlekłego zapalenia wątroby
MX2015002954A (es) 2012-09-10 2015-06-05 Hoffmann La Roche Nuevas 6-aminoacido-heteroarilhidropirimidinas para el tratamiento y profilaxis de la infeccion del virus de la hepatitis b.
WO2015074546A1 (en) 2013-11-19 2015-05-28 Sunshine Lake Pharma Co., Ltd. Dihydropyrimidine compounds and their application in pharmaceuticals
MY172391A (en) 2013-11-27 2019-11-22 Sunshine Lake Pharma Co Ltd Processes for preparing dihydropyrimidine derivatives and intermediates thereof
WO2015144093A1 (en) 2014-03-28 2015-10-01 Sunshine Lake Pharma Co., Ltd. Dihydropyrimidine compounds and their application in pharmaceuticals
JP2018504414A (ja) 2015-02-07 2018-02-15 サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． ジヒドロピリミジン誘導体の複合体及び塩並びにそれらの医薬品への応用
SG10202010180YA (en) 2016-11-18 2020-11-27 Sichuan Kelun Biotech Biopharmaceutical Co Ltd Dihydropyrimidine compound and preparation method and use thereof
US11166954B2 (en) 2016-11-18 2021-11-09 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Dihydropyrimidine compound and preparation method and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH550189A (de) 1971-01-08 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren.
CH569043A5 (xx) 1973-01-23 1975-11-14 Ciba Geigy Ag
SE9702564D0 (sv) * 1997-07-02 1997-07-02 Astra Ab New compounds
DE10012824A1 (de) * 2000-03-16 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013125A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen

Also Published As

Publication number Publication date
EP2135866A4 (en) 2012-02-15
EP2135866B1 (en) 2014-07-02
CN101225084A (zh) 2008-07-23
CN101547919A (zh) 2009-09-30
US20100010013A1 (en) 2010-01-14
EP2135866A1 (en) 2009-12-23
CN101547919B (zh) 2011-11-16
US8106196B2 (en) 2012-01-31
WO2008086729A1 (fr) 2008-07-24

Similar Documents

Publication Publication Date Title
HK1132263A1 (en) Dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis
IL275854A (en) Pharmaceutical composition and its administration
PT2322221E (pt) Composição farmacêutica para tratamento e prevenção de cancro
IL250641B (en) Pharmaceutical preparations for inhibiting nhe-mediated antiport in the treatment of disorders related to fluid retention or salt overload and disorders in the digestive system
IL206296A (en) History of aminopyrazole, and their medicinal products and their use in the preparation of drugs for the prevention and treatment of diseases
IL249165A0 (en) Use of an antigen-mhc complex to prepare drugs for the prevention and treatment of autoimmune conditions
IL218169A (en) Quinazoline compounds and their pharmaceutical compositions containing them for use in therapy
IL193762A (en) The effective compounds in inhibiting dgat1-related disorders, their medicinal products and their use in the preparation of drugs
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
EP2099448A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF RESTENOSIS
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
PL2601962T3 (pl) Schemat dawkowania LAG-3 do stosowania w leczeniu raka
IL200171A (en) Actriib-derived variables, pharmaceutical preparations containing them and their uses for the preparation of medicines
IL195947A (en) Manicured cyclic compounds and pharmaceutical preparations containing them for use @ for prevention @ and treatment @ for diabetes
IL210916A (en) Clonidine and medicinal products containing it for the prevention or treatment of mucosal inflammation
IL212573A (en) Aryl Methyl Benzokinazulinone Compounds
HK1150390A1 (en) A pharmaceutical composition and the application thereof in the preparation of medicine for the treatment of cerebrovascular diseases
IL200278A (en) Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness
IL208355A (en) Annotations 7,3-Dihydroporin-6,2-Discussion, Processes for their Preparation, Pharmaceutical Preparations Containing them and their Use in Medication Preparation
IL205608A (en) History of s-triazole-1-ram-benzamide and their use in the preparation of pain medication
IL193094A (en) Appalidine and other drugs used in the manufacture of a cancer treatment drug when the combination of the two gives a synergistic result
HK1185556A1 (en) Pharmaceutical agent having long-lasting effect of treating arthritic disorders
IL194678A (en) Kinase inhibitors, pharmaceutical preparations containing them and their uses in the preparation of a drug for the treatment of cancer in mammals
IL218277B (en) Tetracycline compounds, pharmaceutical preparations containing them and their use for the preparation of medicines for the treatment and prevention of infection
IL202307A (en) Multikinase inhibitors for use in the preparation of pharmaceuticals for the treatment of various cancers

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191228